Generation of a three-dimensional pharmacophore model (hypothesis) tha
t correlates the biological activity of a series of farnesyl protein t
ransferase (FPT) inhibitors, exemplified by the prototype ,6]cyclohept
a[1,2-b]pyridin-11-ylidene)piperidine, Sch 44342, 1, with their chemic
al structure was accomplished using the three-dimensional quantitative
structure-activity relationship (3D-QSAR) software program, Catalyst.
On the basis of the in vitro FPT inhibitory activity of a training se
t of compounds, a five-feature hypothesis containing four hydrophobic
and one hydrogen bond acceptor region was generated. Using this hypoth
esis as a three-dimensional query to search our corporate database ide
ntified 718 compounds (hits). Determination of the in vitro FPT inhibi
tory activity using available compounds from this ''hitlist'' identifi
ed five compounds, representing three structurally novel classes, that
exhibited in vitro FPT inhibitory activity, IC50 less than or equal t
o 5 mu M. From these three classes, a series of substituted dihydroben
zothiophenes was selected for further structure-FPT inhibitory activit
y relationship studies. The results from these studies is discussed.